Skip to main content
Top
Published in: Antimicrobial Resistance & Infection Control 1/2020

Open Access 01-12-2020 | Letter to the Editor

Active surveillance for highly resistant microorganisms in patients with prolonged hospitalization

Authors: Guido J. H. Bastiaens, Tom Baarslag, Corinne Pelgrum, Ellen M. Mascini

Published in: Antimicrobial Resistance & Infection Control | Issue 1/2020

Login to get access

Abstract

We evaluated a new hospital policy comprising active surveillance for highly resistant microorganisms (HRMO) in patients with prolonged hospitalization, including detection of nosocomial transmission after identification of HRMO carriers. Our findings raise the question of whether active surveillance should be extended from traditional risk groups to patients with prolonged hospitalization.
Literature
5.
go back to reference Buke C, Armand-Lefevre L, Lolom I, Guerinot W, Deblangy C, Ruimy R, et al. Epidemiology of multidrug-resistant bacteria in patients with long hospital stays. Infect Control Hosp Epidemiol. 2007;28:1255–60.CrossRef Buke C, Armand-Lefevre L, Lolom I, Guerinot W, Deblangy C, Ruimy R, et al. Epidemiology of multidrug-resistant bacteria in patients with long hospital stays. Infect Control Hosp Epidemiol. 2007;28:1255–60.CrossRef
6.
go back to reference Friedmann R, Raveh D, Zartzer E, Rudensky B, Broide E, Attias D, et al. Prospective evaluation of colonization with extended-Spectrum β-lactamase (ESBL)–producing Enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing Enterobacteriaceae among patients during hospitalization. Infect Control Hosp Epidemiol. 2009;30:534–42.CrossRef Friedmann R, Raveh D, Zartzer E, Rudensky B, Broide E, Attias D, et al. Prospective evaluation of colonization with extended-Spectrum β-lactamase (ESBL)–producing Enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing Enterobacteriaceae among patients during hospitalization. Infect Control Hosp Epidemiol. 2009;30:534–42.CrossRef
7.
go back to reference Nijhuis RHT, van Maarseveen NM, van Hannen EJ, van Zwet AA, Mascini EM. A rapid and high-throughput screening approach for methicillin-resistant Staphylococcus aureus based on the combination of two different real-time PCR assays. J Clin Microbiol. 2014;52:2861–7.CrossRef Nijhuis RHT, van Maarseveen NM, van Hannen EJ, van Zwet AA, Mascini EM. A rapid and high-throughput screening approach for methicillin-resistant Staphylococcus aureus based on the combination of two different real-time PCR assays. J Clin Microbiol. 2014;52:2861–7.CrossRef
8.
go back to reference Sinnige JC, Willems RJL, Ruijs GJHM, Mascini E, Arends JP, Troelstra A. NVMM Guideline HRMO VRE; 2015. Sinnige JC, Willems RJL, Ruijs GJHM, Mascini E, Arends JP, Troelstra A. NVMM Guideline HRMO VRE; 2015.
9.
go back to reference Nijhuis R, Samuelsen Ø, Savelkoul P, van Zwet A. Evaluation of a new real-time PCR assay (check-direct CPE) for rapid detection of KPC, OXA-48, VIM, and NDM carbapenemases using spiked rectal swabs. Diagn Microbiol Infect Dis. 2013;77:316–20.CrossRef Nijhuis R, Samuelsen Ø, Savelkoul P, van Zwet A. Evaluation of a new real-time PCR assay (check-direct CPE) for rapid detection of KPC, OXA-48, VIM, and NDM carbapenemases using spiked rectal swabs. Diagn Microbiol Infect Dis. 2013;77:316–20.CrossRef
10.
go back to reference Dik JWH, Dinkelacker AG, Vemer P, Lo-Ten-Foe JR, Lokate M, Sinha B, et al. Cost-analysis of seven nosocomial outbreaks in an academic hospital. PLoS One. 2016;11(2):e0149226.CrossRef Dik JWH, Dinkelacker AG, Vemer P, Lo-Ten-Foe JR, Lokate M, Sinha B, et al. Cost-analysis of seven nosocomial outbreaks in an academic hospital. PLoS One. 2016;11(2):e0149226.CrossRef
Metadata
Title
Active surveillance for highly resistant microorganisms in patients with prolonged hospitalization
Authors
Guido J. H. Bastiaens
Tom Baarslag
Corinne Pelgrum
Ellen M. Mascini
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Antimicrobial Resistance & Infection Control / Issue 1/2020
Electronic ISSN: 2047-2994
DOI
https://doi.org/10.1186/s13756-019-0670-8

Other articles of this Issue 1/2020

Antimicrobial Resistance & Infection Control 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.